Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1

The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation

(2014) Stacy P. Ardoin et al.   Modern Rheumatology

HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis

(2012) A.W.S. de Souza et al.   AUTOIMMUNITY REVIEWS

IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKC /Erk1/2/NF- B-dependent signaling pathway

(2012) Y. Liu et al.   INTERNATIONAL IMMUNOLOGY

Intramyocardial Delivery of HMGB1 by a Novel Thermosensitive Hydrogel Attenuates Cardiac Remodeling and Improves Cardiac Function After Myocardial Infarction

(2012) Yi-Yu He et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Overexpression of Human C-Reactive Protein Exacerbates Left Ventricular Remodeling in Diabetic Cardiomyopathy

(2011) Yoshinori Mano et al.   CIRCULATION JOURNAL

HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion

(2011) Zhaoliang Su et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3

(2011) Federica Limana et al.   PLoS One

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer

(2010) Yukiko Moriwaka et al.   PATHOBIOLOGY

Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease

(2010) Gabriela Kania et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy

(2009) Przemyslaw Blyszczuk et al.   CIRCULATION RESEARCH

Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.

(2009) Wojciech Naumnik et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Myocarditis: Infection Versus Autoimmunity

(2009) Noel R. Rose   JOURNAL OF CLINICAL IMMUNOLOGY

The Alarmin Cytokine, High Mobility Group Box 1, Is Produced by Viable Cardiomyocytes and Mediates the Lipopolysaccharide-Induced Myocardial Dysfunction via a TLR4/Phosphatidylinositol 3-Kinase   Pathway

(2009) H. Xu et al.   JOURNAL OF IMMUNOLOGY

HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation

(2009) Elia Ranzato et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury

(2009) Jaklien C. Leemans et al.   PLoS One

CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses

(2009) G.-Y. Chen et al.   SCIENCE

Effects of HMGB1 on Ischemia-Reperfusion Injury in the Rat Heart

(2008) Susumu Oozawa et al.   CIRCULATION JOURNAL

Unknown

(2008) John Klune et al.   MOLECULAR MEDICINE